To address this challenge, researchers have developed MUTE-Seq, a highly sensitive CRISPR-based method designed to detect cancer mutations present at exceptionally low frequencies while simultaneously reducing sequencing costs and background error noise.

The findings are published in the journal Advanced Materials.

The research team was led by Professor Junseok W. Hur from Korea University College of Medicine, in collaboration with multiple partners.